Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LINC00961 gene

Known as: LINC00961, long intergenic non-protein coding RNA 961 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Recently, long noncoding RNA have been identified as new gene regulators and prognostic biomarkers in various cancers, including… Expand
Is this relevant?
2018
2018
Long noncoding RNAs (LncRNAs) expression has been found to be misregulated in multiple human cancers, and a growing number of… Expand
Is this relevant?
2018
2018
Long noncoding RNAs (LncRNAs) have been identified in multiple human cancer types, including lung cancer. An increasing number of… Expand
Is this relevant?
2018
2018
OBJECTIVE Long non-coding RNA LINC00961 (LINC00961) has been reported to play an important role in tumor development and… Expand
Is this relevant?
Highly Cited
2017
Highly Cited
2017
Although long non-coding RNAs (lncRNAs) are non-protein-coding transcripts by definition, recent studies have shown that a… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Long non-coding RNAs (lncRNAs) belong to the ever-increasing number of transcripts that are thought not to encode proteins. A… Expand
  • figure 1
Is this relevant?
2017
2017
Although prematurely baptized as non-coding, some lncRNAs encode polypeptides with regulatory functions that are implicated in… Expand
  • figure 1
Is this relevant?
2017
2017
Lung squamous cell carcinoma (LUSC) accounts for a significant proportion of lung cancer and there have been few therapeutic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
Lung squamous cell carcinoma (LUSC) accounts for a significant proportion of lung cancer and there have been few therapeutic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Primary and acquired drug resistance is one of the main obstacles encountered in high-grade serous ovarian cancer (HGSC… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?